We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Continuous narcotic infusion with patient-controlled analgesia for chronic cancer pain in outpatients.
- Authors
Kerr IG; Sone M; DeAngelis C; Iscoe N; MacKenzie R; Schueller T; Kerr, I G; Sone, M; Deangelis, C; Iscoe, N; MacKenzie, R; Schueller, T
- Abstract
<bold>Study Objective: </bold>To determine the feasibility and safety of outpatient continuous narcotic infusions with additional bolus capabilities (patient-controlled analgesia) in patients with cancer pain.<bold>Design: </bold>A single arm (non-randomized) series.<bold>Setting: </bold>Outpatient with contact by telephone and through outpatient clinic.<bold>Patients: </bold>Consecutive series of 18 patients with poorly controlled cancer pain or significant side effects from regular administration of various narcotics.<bold>Interventions: </bold>Patients taught and supervised to use portable pump capable of delivering a continuous narcotic infusion with bolus capabilities.<bold>Measurements and Main Results: </bold>All patients had improvement in pain control as judged by the use of a linear analogue scale. Side effects and safety profile were highly acceptable. Narcotics used and maximum doses were meperidine, 50 mg/h; morphine, 80 mg/hr; and hydromorphone, 60 mg/hr. Infusion duration ranged from 7 to 225 days (mean, 54 days).<bold>Conclusions: </bold>Continuous narcotic infusions using a programmable portable pump with bolus capabilities is a safe and reliable method of delivering narcotics to outpatients.
- Publication
Annals of Internal Medicine, 1988, Vol 108, Issue 4, p554
- ISSN
0003-4819
- Publication type
journal article
- DOI
10.7326/0003-4819-108-4-554